These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 31784912

  • 1. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
    Tonacchera M, Chiovato L, Bartalena L, Cavaliere AF, Vitti P.
    J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P.
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [Abstract] [Full Text] [Related]

  • 3. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E, Russo L, Orlandi F, Chiovato L, Giusti M, Benvenga S, Moleti M, Vermiglio F, Macchia PE, Vitale M, Regalbuto C, Centanni M, Martino E, Vitti P, Tonacchera M.
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T, Iwaku K, Kobayashi S, Sugino K, Ito K.
    Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
    [Abstract] [Full Text] [Related]

  • 6. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL, Olsen J, Wu CS, Laurberg P.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [Abstract] [Full Text] [Related]

  • 7. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T, Francis N, Lazarus JH, Okosieme OE.
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [Abstract] [Full Text] [Related]

  • 8. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R, Blichowski M, Koren G.
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [Abstract] [Full Text] [Related]

  • 9. Graves' hyperthyroidism in pregnancy.
    Nguyen CT, Mestman JH.
    Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):232-240. PubMed ID: 31389810
    [Abstract] [Full Text] [Related]

  • 10. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 11. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M, Lewis S, Premawardhana L, Dayan CM, Taylor PN, Okosieme OE.
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [Abstract] [Full Text] [Related]

  • 12. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N.
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [Abstract] [Full Text] [Related]

  • 13. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M, Seki T, Ozawa H, Ishihara T, Komatsu M, Tajiri S, Yanagi H, Nishina M, Noh JY, Fukagawa M, Takagi A.
    Endocr J; 2013 Jun; 60(3):383-8. PubMed ID: 23154533
    [Abstract] [Full Text] [Related]

  • 14. [Antithyroid agents and embryopathies].
    Bournaud C, Orgiazzi J.
    Ann Endocrinol (Paris); 2003 Nov; 64(5 Pt 1):366-9. PubMed ID: 15067747
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
    Yoshihara A, Noh JY, Inoue K, Watanabe N, Fukushita M, Matsumoto M, Suzuki N, Suzuki A, Kinoshita A, Yoshimura R, Aida A, Imai H, Hiruma S, Sugino K, Ito K.
    Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
    [Abstract] [Full Text] [Related]

  • 19. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease.
    Taguchi M, Yokota M, Koyano H, Endo Y, Ozawa Y.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):667-70. PubMed ID: 10594530
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.